Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
4 reports, 1 independent
Updated Sep 12
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
Related events
- Financial institutions including Truist Financial, Royal Bank of Canada, and Renaissance Technologies issued rating updates and reported institutional holdings changes to the SEC.
- Truist Financial boosted price target and gave buy rating, and TD Cowen lifted target price and gave buy rating for Encompass Health.
- Truist Financial lowered its target price on Carlisle Companies.
- Truist Financial increased its target price on Albany International.
- Truist Financial reduced its price target on Markel Group.